More News

27 Jul 2017 Jazz Pharmaceuticals and XL-protein GmbH Enter Into a License Agreement on PASylation® Technology to Develop Long-Acting Asparaginase Product Candidates
27 Jul 2017 Complix Announces Expanded Strategic Oncology Collaboration with MSD to Develop Cell-Penetrating Alphabodies
27 Jul 2017 Bavarian Nordic Announces Agreement with Janssen for the Development of Vaccine Regimens against HIV-1 and Hepatitis B
27 Jul 2017 Evotec Expands Collaboration with Storm Therapeutics on Its RNA Epigenetics Platform
27 Jul 2017 Tesaro and Takeda enter into exclusive licensing agreement to develop and commercialize novel cancer therapy niraparib in Japan
27 Jul 2017 AstraZeneca and Merck establish strategic oncology collaboration
25 Jul 2017 Frontier Biotech licenses 3BNC117, a novel broad-spectrum HIV neutralizing antibody
25 Jul 2017 Neon Therapeutics and Apexigen Announce Immuno-Oncology Clinical Trial Collaboration
25 Jul 2017 Takeda and BioSurfaces Announce Joint Research Program to Explore Promising Devices to Treat Gastrointestinal Diseases
25 Jul 2017 BriaCell Expands Targeted Pipeline via Acquisition of Sapientia Pharmaceuticals
25 Jul 2017 ANTABIO Awarded Up to $8.9M from CARB-X to Accelerate the Development of Its New Treatment For Chronic Infections in Cystic Fibrosis Patients
24 Jul 2017 Evotec and Bayer Advance Endometriosis Programme into Phase I Clinical Development and Extend Alliance
24 Jul 2017 Lilly and Nektar Therapeutics Announce Alliance to Develop and Commercialize NKTR-358, A Novel Autoimmune Therapy
24 Jul 2017 NeuroDerm Enters Definitive Agreement to be Acquired by Mitsubishi Tanabe Pharma Corporation for US$1.1 Billion in Cash
21 Jul 2017 Philogen Enters into Multi-Target Research Agreement with Boehringer Ingelheim in the Field Of DNA-Encoded Chemistry
21 Jul 2017 Takeda and Schrödinger Announce Multi-year, Multi-Target Research Collaboration
21 Jul 2017 Aptevo Therapeutics and Alligator Bioscience announce plans to co-develop novel bispecific antibody for tumor-directed immunotherapy
20 Jul 2017 AMO Pharma Enters into Development and License Agreement with Numedicus Limited for Rett Syndrome Program
20 Jul 2017 Ablynx and Sanofi enter into a strategic collaboration to develop nanobody product candidates focused on immune-mediated inflammatory diseases
19 Jul 2017 ViraCyte Enters Exclusive License Agreement with Baylor College of Medicine for T Cell Immunotherapies Targeting Viruses
19 Jul 2017 Invenra Enters Collaboration Agreement with Merck to Identify Therapeutic Antibodies Against Challenging Target
19 Jul 2017 ELSALYS BIOTECH and the prestigious German cancer research institute DKFZ initiate the development of ELB021 in B-Cell leukemia with the support of EU
19 Jul 2017 Amgen And Array BioPharma Announce Preclinical License And Collaboration Agreement In Inflammation
18 Jul 2017 Shire Expands Broad Monoclonal Antibody Research Platform, Enters License Agreement for Novimmune Bi-specific Antibody
18 Jul 2017 PeptiDream and Kleo Pharmaceuticals Announce Collaboration Agreement to Develop Novel Immunotherapies for Oncology

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing